- PARP inhibitors in ovarian cancer: evidence, experience and clinical potential.
Evans Tarra et al. Therapeutic advances in medical oncology 2017 Apr 9(4) 253-267
- Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer.
Hollis Robert L et al. OncoTargets and therapy 2017 102539-2551
- Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer.
Hermel David J et al. Clinical breast cancer 2017 Apr
- Why Would Men Need Genetic Testing for Breast Cancer Too?
Cleveland Clinic Health Essentials
- Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families.
Healey Emma et al. Genetics in medicine : official journal of the American College of Medical Genetics 2017 May
lunes, 12 de junio de 2017
BRCA MUTATIONS|https://phgkb.cdc.gov/GAPPKB/phgHome.do|BRCA MUTATIONS
From From Genomics & Health Impact Scan Database
This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.